Cell Marque IVD antibodies are only tested for use on human tissue in a clinical setting with immunohistochemistry only. No other methods such as Fluorescence or Flow Cytometry or western blot or other species such as mouse, rabbit, monkey, etc. have been qualified to work with those antibodies.
405M-1
FOXA1 (2F83) Mouse Monoclonal Antibody
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| A voi/SKU | Disponibilità | Prezzo |
|---|
Informazioni su questo articolo
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
2F83, monoclonal
Application:
IHC (p)
Citations:
2
Prezzi e disponibilità al momento non sono disponibili
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartibiological source
mouse
conjugate
unconjugated
antibody form
culture supernatant
antibody product type
primary antibodies
clone
2F83, monoclonal
description
For In Vitro Diagnostic Use in Select Regions (See Chart)
form
buffered aqueous solution
species reactivity
human
packaging
vial of 0.1 mL concentrate (405M-14), vial of 0.5 mL concentrate (405M-15), bottle of 1.0 mL predilute (405M-17), vial of 1.0 mL concentrate (405M-16), bottle of 7.0 mL predilute (405M-18)
manufacturer/tradename
Cell Marque®
technique(s)
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:25-1:100
isotype
IgG1κ
control
breast carcinoma
shipped in
wet ice
storage temp.
2-8°C
visualization
nuclear
Gene Information
human ... FOXA1(3169)
General description
Forkhead box A1 (FOXA1), also known as hepatocyte nuclear factor 3 alpha(HNF3a), is a transcription factor expressed in normal breast ductal epithelium and other epithelium in different organs, such as lung, pancreas, bladder, prostate, and colon. It has been reported to co-express with ER in breast carcinoma, predominantly in luminal subtype A.[1][2] FOXA1 expression has been identified in 42% - 75% of invasive carcinoma of the breast.[1][2] Of the FOXA1-positive breast invasive carcinomas, 83% were comprised of ER+/PR+/Her2+ luminal A subtype.[1] The results indicate that anti-FOXA1 is useful in the sub-classification of breast carcinoma.
Physical form
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
Preparation Note
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
Analysis Note
 IVD |  IVD |  IVD |  RUO |
Other Notes
FOXA1 Positive Control Slides, Product No. 405S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
For Technical Service please contact: 800-665-7284 or email: [email protected]
Legal Information
Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Provate il nostro Motore di ricerca dei prodotti per restringere le opzioni.
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
-
Does the FOXA1 (2F83) antibody only react to human cells, or does it also react to mouse cells?
1 answer-
Helpful?
-